SALT LAKE CITY, Nov. 17, 2009 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (Nasdaq:MYGN) announced today that Peter D. Meldrum, President and CEO, is scheduled to present an overview of the Company at the 21st Annual Piper Jaffray Health Care Conference, at 9:30 a.m. Eastern on December 1, 2009, at the New York Palace Hotel in New York City.
